X-133754180-TAAAAAA-TAAAAAAAA
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS1
The NM_004484.4(GPC3):c.338-6_338-5dupTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000065 ( 0 hom., 1 hem., cov: 19)
Exomes 𝑓: 0.0024 ( 0 hom. 0 hem. )
Consequence
GPC3
NM_004484.4 splice_region, intron
NM_004484.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.883
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant X-133754180-T-TAA is Benign according to our data. Variant chrX-133754180-T-TAA is described in ClinVar as [Likely_benign]. Clinvar id is 1692814.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0000654 (5/76495) while in subpopulation AFR AF= 0.000146 (3/20618). AF 95% confidence interval is 0.0000395. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 19. This position pass quality control queck.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000654 AC: 5AN: 76495Hom.: 0 Cov.: 19 AF XY: 0.0000560 AC XY: 1AN XY: 17847
GnomAD3 genomes
AF:
AC:
5
AN:
76495
Hom.:
Cov.:
19
AF XY:
AC XY:
1
AN XY:
17847
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00240 AC: 2057AN: 858102Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 249560
GnomAD4 exome
AF:
AC:
2057
AN:
858102
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
249560
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000654 AC: 5AN: 76495Hom.: 0 Cov.: 19 AF XY: 0.0000560 AC XY: 1AN XY: 17847
GnomAD4 genome
AF:
AC:
5
AN:
76495
Hom.:
Cov.:
19
AF XY:
AC XY:
1
AN XY:
17847
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
GPC3-related disorder Benign:1
Aug 09, 2019
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Hereditary cancer-predisposing syndrome Benign:1
Jul 21, 2021
Sema4, Sema4
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: curation
- -
Simpson-Golabi-Behmel syndrome type 1;CN033288:Wilms tumor 1 Benign:1
Dec 06, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at